Kent Hospital cancer program earns accreditation
The Commission on Cancer (CoC) of the American College of Surgeons (ACoS) has granted three-year accreditation with commendation to the Cancer Program at Kent Hospital for the second consecutive time. To earn voluntary CoC accreditation, a cancer program must meet or exceed 34 CoC quality care standards, be evaluated every three years through a survey process and maintain levels of excellence in the delivery of comprehensive patient-centered care. Three-year accreditation with commendation is only awarded to a facility that exceeds standard requirements at the time of its triennial survey.
“Receiving accreditation with commendation is a major accomplishment for the Cancer Program at Kent Hospital and reiterates that our facility is dedicated to providing the best in patient-centered cancer care,” Sandra Coletta, COO Care New England, president and CEO of Kent Hospital, said in a statement. “There are many factors involved in receiving this national accreditation and I am extremely proud of the hard work that is done every day by the physicians, nurses and staff that make up Kent’s Cancer Program.”
“The mission of the Cancer Program at Kent is to provide our patients with the best quality care and in a most compassionate fashion that promotes healing and hope,” said Bachir Sakr, MD, medical oncologist and chair of the cancer committee at Kent Hospital. “Our focus is to give our patients the best chance for a cure whenever possible, applying evidence-based medicine and using the most advanced technology available.”
The CoC Accreditation Program provides the framework for Kent Hospital to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care, including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, lifelong follow-up for recurrent disease and end-of-life care. When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling and patient-centered services, including psycho-social support, a patient navigation process and a survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life.
Like all CoC-accredited facilities, Kent maintains a cancer registry and contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society (ACS). This nationwide oncology outcomes database is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care. CoC-accredited cancer centers, in turn, have access to information derived from this type of data analysis, which is used to create national, regional and state benchmark reports. These reports help CoC facilities with their quality improvement efforts.
The ACS estimates that more than 1.6 million cases of cancer will be diagnosed in 2014. There are currently more than 1,500 CoC-accredited cancer programs in the U.S. and Puerto Rico, representing 30 percent of all hospitals. CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed cancer patients. When cancer patients choose to seek care locally at a CoC-accredited cancer center, they are gaining access to comprehensive, state-of-the-art cancer care close to home. The CoC provides the public with information on the resources, services and cancer treatment experience for each CoC-accredited cancer program through the CoC Hospital Locator at www.facs.org/cancerprogram/index.html.